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Unfavorable course of minimal change nephrotic syndrome in
children with intrauterine growth retardation.
Background. Intrauterine growth retardation (IUGR) is associ-
ated with higher morbidity and mortality not only in perinatal life
but also in later life. The purpose of our study was to determine
whether IUGR has any effect on the course of minimal change
nephrotic syndrome (MCNS) in children.
Methods. Forty children who were between 1 and 16 years old at
the onset of MCNS, who have been followed for at least three
years and for whom we were able to obtain birth weights and
gestational ages, were included. The diagnosis of MCNS was
predicted on the basis of clinical and laboratory features, and in 11
children (27.5%) the diagnosis was confirmed by renal biopsy.
IUGR was defined as birth weight below the tenth percentile for
gestational age.
Results. Five children (12.5%) had signs of IUGR at birth. In
children with IUGR, we observed a higher mean number of
relapses (10.4 vs. 3.3, P , 0.001) and a higher incidence of steroid
dependency (80% vs. 21%, P , 0.02) than in children without
IUGR. Other differences between children with and those with-
out IUGR included more frequent treatment with cytotoxic
agents and cyclosporine, and a higher incidence of renal biopsy in
children with IUGR.
Conclusion. Our study demonstrated an unfavorable course of
MCNS in children with IUGR. IUGR could therefore enable
early identification of those children who are at risk of becoming
frequent relapsers and of developing steroid dependency. This,
however, should be confirmed in a larger number of patients.
It is generally accepted that intrauterine growth retarda-
tion (IUGR) with subsequent low birth weight for gesta-
tional age is associated with higher morbidity and mortality
in neonatal and perinatal life [1]. The results of recent
studies suggest that IUGR is also associated with higher
morbidity and mortality in later life [2, 3]. These recent
studies have demonstrated that persons who had signs of
IUGR at birth are at higher risks of developing essential
hypertension [4, 5], ischemic heart disease [6], diabetes
mellitus [7], and chronic obstructive lung disease [8]. The
mechanisms of these associations are still poorly under-
stood, but it is believed that impaired growth during fetal
life results in long-term changes in physiology or metabo-
lism of organs, making them more susceptible for the
development of some diseases in later life [2]. It has been
postulated that IUGR also affects the development of the
fetal kidney and could therefore affect the clinical course
and prognosis of renal diseases [9–11]. In our study, we
wished to determine whether IUGR has any effect on the
clinical course of minimal change nephrotic syndrome
(MCNS) in children.
METHODS
Patients
Our study included children between 1 and 16 years of
age with MCNS referred to the Pediatric Hospital in
Ljubljana between 1984 and 1993. At least three-year
follow-up was thus possible.
Nephrotic syndrome was defined as proteinuria . 40
mg/m2 z hr, plasma albumin , 25 g/liter, and the presence
of edema and hyperlipidemia. Diagnosis of MCNS was
predicted on the basis of clinical and laboratory features
[12]. Renal biopsy was performed in children who did not
respond to initial treatment with corticosteroids, who had
frequent relapses, and/or who had initial hematuria. Corti-
costeroid resistance and dependency, as well as remission
and relapse were defined according to the generally ac-
cepted criteria [12, 13].
Initial attack and relapses were treated by methylpred-
nisolone 0.8 to 1.2 mg/kg per day until remission plus one
week, followed by alternate-day methylprednisolone of 1
mg/kg per 48 hours for four more weeks.
Birth weights and gestational ages were obtained from
the records of the Slovene maternity hospitals and from the
records of the pediatric files. IUGR was defined as birth
weight below the tenth percentile for gestational age. We
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used the growth rate curves for single births in Slovenia
[14].
The study was approved by the State Ethical Committee.
Statistical analysis
Numerical variables were analyzed by Student’s t-test; if
the distribution of values within the variables was not
normal, the Wilcoxon test was applied. Attributive vari-
ables were analyzed by Fisher’s exact test. Differences were
considered to be statistically significant at P # 0.05.
RESULTS
During a 10-year period, 42 patients with MCNS were
treated at the Pediatric Hospital in Ljubljana. Two children
with MCNS were not included in the study because we were
not able to obtain their birth weights.
Among the 40 children included in our study, 16 were
girls and 24 were boys, aged 14 months to 14 years (mean
5.8 6 3.9 years). In 11 patients (27.5%), the diagnosis of
MCNS was confirmed by renal biopsy (in 3 of 5 children
with IUGR, and in 8 of 35 children without IUGR, P 5
0.08).
Patients’ birth weights and gestational ages
Five of the 40 children with MCNS (12.5%) had signs of
IUGR at birth. Their birth weights ranged from 1940 g to
3000 g (mean 2528 6 410), and they were born between the
36th and 42nd weeks of gestation. The remaining 35 patients
(87.5%) had no signs of IUGR at birth, their birth weights
ranged from 2500 to 4200 g (mean 3446 6 438), and they
were born between the 36th and 42nd weeks of gestation.
Children with IUGR were of similar age at the onset of
MCNS (5.8 6 4.5 vs. 5.8 6 3.8, NS), and have been
followed for a similar period (6.4 6 1.1 vs. 6.1 6 2.7, NS) as
children without IUGR.
Treatment of nephrotic syndrome and response to
treatment with corticosteroids
In two children, no specific treatment of the nephrotic
syndrome was necessary because spontaneous remission
occurred. The remaining 38 patients were treated with
corticosteroids (Tables 1 and 2). The initial treatment with
corticosteroids induced remission within four weeks in all
but one patient, and all patients remained steroid-respon-
sive throughout the course of the MCNS. In the child who
did not respond to corticosteroids, remission was achieved
after treatment with cyclosporine. In the subsequent
course, 11 children (28.9%) developed signs of steroid
dependency. Additionally to corticosteroids, treatment with
cytotoxic drugs was indicated in 14 (35.0%) children and
with cyclosporine in 4 children (10.0%).
Comparison between children with and those without
IUGR revealed statistically significant differences in the
incidence of steroid dependency (P , 0.02) and in the
incidence of treatment with cytotoxic drugs (P , 0.05).
Other differences between the two groups of children were
not statistically significant.
Frequency of relapses
Children were followed for 3 to 11 years (mean 6.1 6
2.6). Thirteen of the 40 children (32.5%) had no relapses
(Table 3). The remaining 27 children (67.5%) followed a
relapsing course, with 1 to 16 relapses (mean 4.2 6 4.5).
Comparison between children with and those without
IUGR revealed a statistically significant difference in mean
number of relapses (10.4 vs. 3.3, P , 0.001). Other differ-
ences between the two groups of children were not statis-
tically significant.
Frequency of complications of the nephrotic syndrome
and of concomitant diseases
In all but two children, the innitial attack and/or the
majority of relapses, if present, were associated with upper
Table 1. Treatment of 40 children with minimal change nephrotic
syndrome divided into two groups on the basis of their birthweights
Total
(N 5 40)
Birthweight
, 10th percentile
(N 5 5)
Birthweight
. 10th percentile
(N 5 35) P
Corticosteroids 38 5 33 NS
95.0% 100% 94.3%
Cytotoxic drugs 14 4 10 , 0.05
35.0% 80.0% 28.6%
Cyclosporine 4 2 2 , 0.07
10.0% 40.0% 5.8%
Table 2. Response of 38 children with minimal change nephrotic
syndrome to treatment with corticosteroids
Total
(N 5 38)
Birthweight
, 10th percentile
(N 5 5)
Birthweight
. 10th percentile
(N 5 33) P
Responders 37 5 32 NS
97.4% 100% 97.0%
Non-responders 1 1 NS
2.6% 3.0%
Corticosteroid- 11 4 7 , 0.02
dependent 28.9% 80.0% 21.2%
The patients are divided into 2 groups on the basis of their birthweights.
In 2 patients, spontaneous remission occurred without specific treatment,
and are not included in the table.
Table 3. Mean number of relapses in 40 children with minimal change
nephrotic syndrome divided into two groups on the basis of their
birthweights
Total
(N 5 40)
Birthweight
, 10th percentile
(N 5 5)
Birthweight
. 10th percentile
(N 5 35) P
No relapses 13 1 12 NS
32.5% 20.0% 34.3%
Mean number 4.2 6 4.5 10.4 6 6.2 3.3 6 3.5 , 0.001
of relapses
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respiratory tract infections or bronchopneumonia. Arterial
hypertension was transient in all patients and tended to be
more frequent in children with IUGR than in those without
IUGR. Comparison between children with and those with-
out IUGR did not reveal any significant differences in the
frequency of important complications of the nephrotic
syndrome and in the frequency of concomitant diseases.
DISCUSSION
The results of our study indicate that IUGR predicts an
unfavorable clinical course of MCNS in children. Children
with MCNS who had had signs of IUGR at birth have had
a significantly higher mean number of relapses than chil-
dren without IUGR. Furthermore, a significantly higher
percentage of children with IUGR developed steroid de-
pendency. Other differences between children with and
those without IUGR include more frequent treatment with
cytotoxic agents and cyclosporine, and a higher incidence of
renal biopsy in children with IUGR. More agressive treat-
ment and a higher incidence of renal biopsy in children with
IUGR are probably due to more frequent relapses and
steroid dependency observed in these children.
The ability to predict the course and outcome in children
with MCNS may have significant therapeutic implications.
Previous attempts to correlate the course and outcome of
MCNS with the clinical, laboratory, and histologic charac-
teristics have met with only limited success [15–18]. The
best predictive value has been demonstrated for the num-
ber of relapses during the first six months [17, 18] and the
characterization of the initial response to corticosteroids
[18]. Our study has demonstrated a good predictive value
for IUGR also, which could help to identify those children
who are more likely to have frequent relapses and to
develop steroid dependency even earlier in the course of
MCNS. However, these conclusions should be drawn with
caution as our study included a rather small number of
patients with MCNS. Furthermore, it must be emphasized
that the diagnosis of MCNS was confirmed by renal biopsy
only in 11 children; in the remaining 29 children it was
predicted on the basis of the clinical and laboratory fea-
tures [12].
The results of our study provide further support for a
recent hypothesis that IUGR with subsequent low birth
weight for gestational age might be one of the non-immune
mechanisms affecting the clinical course and prognosis of
renal diseases [9–11]. Previous studies have demonstrated
that patients with diabetes mellitus who had had signs of
IUGR at birth are at increased risk of the development of
diabetic nephropathy [19, 20]. Furthermore, in 12 patients
with idiopathic membranous nephropathy, a strong corre-
lation has been found between the patients’ birth weights
and the slopes of the reciprocal creatinine regression lines
[21]. Finally, we have found a higher incidence of arterial
hypertension and glomerulosclerosis in children with IgA
glomerulonephritis who had suffered from IUGR, than in
children with IgA glomerulonephritis without IUGR [22].
The effect of IUGR on the clinical course of some renal
diseases, such as IgA glomerulonephritis and diabetic ne-
phropathy, can be explained by the low number of
nephrons. Namely, it has been demonstrated that children
[23] and experimental animals [24] with IUGR have a lower
number of nephrons (glomeruli) than those without IUGR.
Furthermore, our preliminary study revealed a lower glo-
merular density in individuals with low birth weight [25].
Individuals with a low number and a lower density of
nephrons (glomeruli) have a diminished renal functional
reserve and are therefore at higher risk of progression of
renal diseases [9–11]. However, this mechanism does not
explain the effect of IUGR on the clinical course of MCNS.
The effect of IUGR on the clinical course of MCNS could
be related to a higher morbidity described in children with
IUGR [1], although we haven’t observed any significant
differences in the frequency of concomitant diseases and
complications of the nephrotic syndrome between children
with and those without IUGR. It is therefore possible that
IUGR not only results in a reduction of the total number of
nephrons, but also in other changes in the morphology
and/or physiology of the developing kidney, which are still
poorly understood.
In conclusion, our study demonstrated an unfavorable
clinical course of MCNS in children with IUGR. IUGR
could therefore enable early identification of those children
with MCNS who are at risk of becoming frequent relapsers
and of developing steroid dependency. These findings,
however, should be confirmed in a larger number of
patients.
Table 4. Frequency of important complications of the nephrotic
syndrome and of concomitant diseases in 40 children with minimal
change nephrotic syndrome divided into two groups on the basis of
their birthweights
Total
(N 5 40)
Birthweight
, 10th percentile
(N 5 5)
Birthweight
. 10th percentile
(N 5 35) P
Microhematuria 7 1 6 NS
17.5% 20.0% 17.1%
Arterial 5 2 3 NS
hypertension 12.5% 40.0% 8.6%
Hypovolemic 2 0 2 NS
shock 5.0% 5.7%
Actue renal 1 0 1 NS
failure 2.5% 2.9%
Upper respiratory 35 4 31 NS
tract infections 87.5% 80.0% 88.6%
Bronchopneumonia 3 0 3 NS
7.5% 8.6%
Urinary tract 2 0 2 NS
infections 5.0% 5.7%
Othera 3 0 3 NS
7.5% 8.6%
a Asthma in one patient, vesicoureteral reflux in two patients
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